Related Experiment Video
Updated: Jun 2, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
MMP-2 and MMP-9 are prominent matrix metalloproteinases during atherosclerosis development in the
Dick Wågsäter1, Chaoyong Zhu, Johan Björkegren
1Atherosclerosis Research Unit, Center for Molecular Medicine, Department of Medicine, Karolinska Institute, Solna, Stockholm, Sweden. dick.wagsater@ki.se
Abstract:
Matrix-degrading proteases capable of degrading components of the extracellular matrix may play an important role in development and progression of atherosclerotic lesions. In the present study, we used the Ldlr(-/-)Apob(100/100) mouse model, which has a plasma lipoprotein profile similar to that of humans with atherosclerosis, to study the expression of matrix metalloproteinases (MMPs) during early stages of atherosclerosis development. We analyzed the expression of 11 proteases and three protease inhibitors in 5- to 40-week-old Ldlr(-/-)Apob(100/100) mice. Expression and activity of MMP-2 and MMP-9 was increased in advanced atherosclerotic lesions followed by macrophage infiltration as shown by real-time PCR, gel-based and in situ zymography and immunohistochemistry. Expression of other investigated MMPs did not increase during disease progression. However, the mRNA expression of MMP-8 and MMP-13 was down-regulated, which could explain the relatively high amount of collagen observed in the vessels in this model. In conclusion, low proteolytic expression at early stages of atherogenesis and a limited repertoire of proteolytic enzymes were associated with the progression of atherosclerosis in Ldlr(-/-)Apob(100/100) mice. The study suggests that MMP-2 and MMP-9 are the main proteases involved in atherogenesis in this mouse model.
Insights
Matrix-degrading proteases like matrix metalloproteinases (MMPs) are crucial in atherosclerosis. This study found MMP-2 and MMP-9 expression increased in advanced lesions, suggesting their key role in disease progression.
Area of Science:
- Cardiovascular Biology
- Protease Biochemistry
- Atherosclerosis Research
Background:
- Extracellular matrix-degrading proteases influence atherosclerotic lesion development.
- Understanding matrix metalloproteinase (MMP) roles is vital for atherosclerosis research.
Purpose of the Study:
- To investigate matrix metalloproteinase (MMP) expression during early atherosclerosis in a relevant mouse model.
- To identify specific MMPs involved in the progression of atherosclerotic lesions.
Main Methods:
- Utilized Ldlr(-/-)Apob(100/100) mice, mimicking human lipoprotein profiles.
- Analyzed expression of 11 proteases and 3 inhibitors across 5-40 weeks.
- Employed real-time PCR, zymography, and immunohistochemistry to assess MMP activity and localization.
Main Results:
- MMP-2 and MMP-9 expression and activity significantly increased in advanced atherosclerotic lesions with macrophage infiltration.
- Expression of other MMPs did not consistently increase; MMP-8 and MMP-13 mRNA were downregulated.
- Downregulation of MMP-8 and MMP-13 may correlate with higher collagen levels in vessels.
Conclusions:
- Low proteolytic activity in early atherogenesis and a limited protease repertoire are linked to atherosclerosis progression in this model.
- MMP-2 and MMP-9 are identified as the primary proteases driving atherogenesis in the Ldlr(-/-)Apob(100/100) mouse model.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
Atherosclerosis I: Introduction

